Malignant Mesothelioma ONCONASE (ranpirnase) Trial Goal Reached

Alfacell Achieves Full Patient Enrollment Milestone for the ONCONASE Phase IIIb Registration Study in Unresectable Malignant Mesothelioma

BLOOMFIELD, N.J., Feb. 27 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL - News) today announced that the full enrollment target of 316 patients has been reached for the international, confirmatory Phase IIIb registration trial evaluating ONCONASE® (ranpirnase), the Company's lead investigational drug candidate, as a treatment for unresectable malignant mesothelioma (UMM).

The Company has developed and managed one of the largest UMM clinical programs ever undertaken. Over 600 UMM patients have been enrolled in the ONCONASE UMM study, including newly-diagnosed and refractory patients treated with ONCONASE as a single agent and in combination with doxorubicin.

"We are pleased to have achieved this important milestone ahead of schedule, and look forward to completion of all other regulatory requirements for the marketing approval of ONCONASE in the U.S., E.U. and other markets," stated Kuslima Shogen, Chief Executive Officer of Alfacell.

About the ONCONASE Phase IIIb Registration Study

ONCONASE is being evaluated at over 40 investigator sites across 10 countries in a centrally-randomized, open-label Phase IIIb trial as a treatment for UMM, an asbestos-related cancer that afflicts approximately 10,000 people worldwide -- including 4,000 in the U.S. -- each year. The study is being conducted to determine whether survival is prolonged in UMM patients treated with ONCONASE in combination with doxorubicin compared to doxorubicin alone. The estimated global UMM market is $300 million.

About ONCONASE

ONCONASE is a first-in-class therapeutic from Alfacell's proprietary ribonuclease (RNase) technology platform. ONCONASE has been shown to target tumor cells while sparing normal cells. ONCONASE is internalized by endocytosis and released into the cytosol of the cancerous cell, where it selectively degrades tRNA beyond repair. In doing so, ONCONASE inhibits protein synthesis, stops cell cycle proliferation, and induces apoptosis (programmed cell death).

ONCONASE has previously been granted Orphan Drug designation from EMEA and TGA (Australia), as well as Fast Track status by the FDA. The latter has enabled the Company to complete and submit sections of the New Drug Application (NDA) on an accelerated, rolling basis.

In addition to the Phase IIIb UMM registration trial, the Company is conducting an ONCONASE Phase I / II trial in Non-Small Cell Lung Cancer (NSCLC). The NSCLC market is expected to exceed $4 billion by 2012.

Also, pre-clinical studies examining ONCONASE conjugates as potential treatments for gliomas and Non-Hodgkins Lymphoma (NHL) are being conducted at Johns Hopkins University and the National Cancer Institute (NCI), respectively.

Who's Stealing Your Health Records?

Get the Scoop on the 7 Hottest Topics in Healthcare 
 
Augusta, MI  - 49012 - March 29 2006 
 
Get The Scoop On The 7 Hottest Topics In Healthcare!

 

1. Who's Stealing Your Health Records?
Healthcare Privacy/HIPAA - Hundreds of medical records are lost everyday due to neglect and theft. Are your healthcare records safe? What will happen to you if they fall into the hands of a rogue medical worker or identity thief? How can healthcare organizations and patients protect themselves?

 

2. Bracing for Disaster
The State of Emergency Care Systems in the US - How well can the current healthcare system deal with another hurricane or terrorist attack? How would the displacement of millions of Americans affect your ability to get the health services you need? How can hospitals, medical offi ces, and patients prevent the loss of medical records?

 

3. Risky Records
The Truth About EHRs - Following Hurricane Katrina, many healthcare providers have made the switch to Electronic Health Records. What they don't know is that many Electronic Health Record systems may be producing incomplete records that won't stand up to scrutiny in a legal or administrative proceeding. How can you tell if your records are complete and accurate? How can you fix the problem without buying a new system?

 

4. Price Gouging Patients
Healthcare Insurance - 60 Minutes broke the story first: Uninsured patients are being charged up to 4 times that of insured patients due to a misunderstanding in the regulations. Why? And what can we do about it?

 

5. Dirty Doctors
Sexual Harassment in the Medical Environment - Hospitals and doctor's offices have some of the highest incidents of harassment among any work environment. Why is this and what can we do as patients and workers to protect ourselves?

 

6. Is Your Doctor Following the Rules?
Healthcare Compliance - Doctors and hospitals must follow strict government regulations. Find out what they are and what to do if your healthcare provider is not following the rules.

 

7. Medicare/Medicaid
What Do The Changes Mean for You? - How do changes in Medicare/Medicaid laws affect patients and healthcare providers? Are the changes good or bad? What changes still need to be made?

 

Nation's #1 healthcare compliance expert comments on breaking health news.

 

Patricia Trites, CHCC, CPC, CHP is one of the nation's leading experts on Medicare, Medicaid, disaster recovery, and the healthcare compliance laws protecting your health, your privacy, and your money. She is CEO of Healthcare Compliance Resources, LLC (www.ComplianceResources.com), a company that provides compliance certification, training, and resources for healthcare organizations and professionals. She sits on the editorial advisory boards of the industry's top publications, and is the author of the Healthcare Organization and Medical Office Compliance Program Guide, Compliance Guide for the Medical Practice, and Due Diligence evaluating EHR Systems: A Hands on Manual for the Compliant EMR Before and After Purchase. 
 
Patricia Trites (pati@complianceresources.com)
CEO
Healthcare Compliance Resources
507 W. Jefferson
Augusta, MI   49012
Phone : 269-731-2561
Fax : 269-731-4346 

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or defend
your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
http://www.drug-store-directory.com
__________________________________________________

Waiting Room Patients Targeted In Sick Scheme

VISI Networks Teams with LabCorp(R) to Launch LabCorp Health Network; A Direct-to-Patient Digital Signage Network for LabCorp's Patient Service Centers Nationwide
 
LabCorp Health Network (LHN) - a direct-to-patient digital signage network for LabCorp's Patient Service Centers - is a customized channel of healthcare information specifically designed to provide patients using LabCorp's patient service centers a comfortable waiting environment through the delivery of quality commercial, educational, informational and entertainment segments via an internet driven, nationally networked narrowcast system. (Photo: Business Wire)

 

ORLANDO, Fla.--(BUSINESS WIRE)--March 28, 2006--VISI Networks and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), a leading, national provider of diagnostic services and a pioneer in new diagnostic technologies, have teamed to create the LabCorp Health Network - a direct-to-patient digital signage network for LabCorp's Patient Service Centers.

 

The LabCorp Health Network (LHN) is a customized channel of healthcare information specifically designed to provide patients using LabCorp's patient service centers a comfortable waiting environment through the delivery of quality commercial, educational, informational and entertainment segments via an internet driven, nationally networked narrowcast system. Presented on large, flat-panel screens installed in LabCorp's Patient Service Centers, LHN provides an opportunity for advertisers and content partners to reach a health conscious audience with known demographic and statistical data.

 

"Through the LabCorp Health Network, we are providing a dynamic channel to educate patients and visitors as to the latest testing procedures and preventive measures they can take to lead happier and healthier lives," said Joseph Erhart, CEO of VISI Networks.

 

"We are extremely excited about this network. This private channel represents an opportunity for LabCorp and their content partners to reach a sizeable health conscious audience with relevant messaging that connects directly with their customer base in a way that was previously impossible," said Michael Erhart, VP of Business Development for VISI Networks. "By being able to deliver messages directly to real patients - ensuring they receive the most up-to-date information in a timely manner - this narrowcast network establishes itself as a superior alternative to traditional media."

 

Currently, the LabCorp Health Network can be found in over 300 of LabCorp's more than 1,300 Patient Service Centers in the U.S.

 

About VISI Networks

 

Founded by nationally recognized wayfinding and signage information display system expert Joseph Erhart, VISI Networks develops proprietary network information display systems capable of delivering high-impact digital multimedia messages to targeted consumers. VISI Networks has tested their infrastructure with networks in Florida Hospital Critical Care Centers, SunTrust Bank and Orlando-Sanford International Airport. To learn more about VISI Networks, visit www.VISInetworks.com.

 

About LabCorp(R)

 

Laboratory Corporation of America(R) Holdings, a S&P 500 company with an investment-grade credit rating, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $3.3 billion in 2005, approximately 24,000 employees nationwide, and more than 220,000 clients, LabCorp offers clinical assays ranging from routine blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, in Research Triangle Park, NC; National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN; The Center for Esoteric Testing in Burlington, NC; DIANON Systems, Inc. based in Stratford, CT, US LABS based in Irvine, CA, and Esoterix and its Colorado Coagulation, Endocrine Sciences, and Cytometry Associates laboratories. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about LabCorp, visit www.LabCorp.com.

 

Contacts
Media Contacts
Tier 1 Public Relations
Dan Dyer, 513-478-7818
ddyer@tier1pr.com
or
LabCorp
Pam Sherry, 336-436-4855
sherryp@labcorp.com
OR
Advertising Contact
VISI Networks Inc.
Jenny Sue Rhoades, 407-566-1437
jennysue@visinetworks.comAt A Glance
VISI Networks
Source: via Business Wire
Updated  03/24/2006  by company 

---

[Editor's comments: Great. Now when I have to see a doctor I can look forward to having my desperate-for-a-distraction mind feed commercial messages not unlike waiting for a plane at the airport. I predict the day is near when you use a public restroom and close the door you will sit (or stand) to have a yammering screen that wants to take your moment of privacy and join you for a little marketing one-on-one.

 

It's information.  It's advertising.  It's intrusive.  And It's obnoxious.

 

(hris ]

Early Detection Tests For Conditions Leading to Mesothelioma Sought

New Tests in Development For Early Detection of Conditions Leading to Mesothelioma

 

High blood levels of a protein called osteopontin are linked to the development of pleural mesothelioma 

 

The key to curing any disease is early detection and progress has been made for an early-detection test that could improve survival for people with a deadly cancer linked to asbestos exposure.

 

High blood levels of a protein called osteopontin are linked to the development of pleural mesothelioma, an asbestos-related cancer that invades the chest cavity and the lining of the lungs.

 

In a recent article in the New England Journal of Medicine, Dr. Harvey Pass, professor of surgery at New York University School of Medicine said, "The earlier you detect it, the better the chance that you can do therapy that impacts survival,"

 

Mesothelioma Screening Still Eludes
There is currently no way to screen for mesothelioma, a potential hazard for the 7.5 million American workers with a history of workplace exposure to asbestos. Those people include foundry workers, miners, shipbuilders and an estimated 1.5 million maintenance and construction workers. The challenge is to single out those who will develop the cancer from those with other asbestos-related lung conditions.
Although the work is preliminary, osteopontin levels may point to heightened mesothelioma risk, Pass said. The findings are based on a study of 190 people -- 69 with noncancerous asbestos-related disease, 76 with mesothelioma and 45 smokers with no exposure to asbestos.

 

Blood tests showed that the levels of osteopontin rose along with years of asbestos exposure -- the lowest levels were in people exposed to asbestos for less than 10 years, while levels doubled for people with more than 10 years of exposure and increased steadily with asbestos-caused damage to the lungs.

 

Blood concentrations of osteopontin were six times normal levels in people with mesothelioma, even during the early stages of the disease, the researchers found.

 

A blood marker that helped doctors catch the disease early could offer patients real hope, Pass said. "If you find that this marker of risk is high, you can take action, starting with CT scanning to detect the disease early," he noted.

 

Osteopontin Test May be Flawed
But that optimism was not echoed by Dr. Mark R. Cullen, a professor of medicine and public health at Yale University, who wrote an accompanying editorial. Longer survival through early detection has been shown in breast cancer, colon cancer and some other malignancies, Cullen said, but the evidence for it in mesothelioma is weak. It is possible that detecting an inevitably fatal cancer early gives the illusion of longer survival, since the time after diagnosis is longer than if the tumor is detected closer to death, he noted.

 

And the osteopontin test has a major weakness, Cullen said. It lacks specificity, which means it also detects other, less fatal conditions, putting those patients through testing that might be unnecessary.

 

Nevertheless, he said, "I strongly encourage this kind of research in the hope that many good things might come of it -- an early blood test, a very good diagnostic test, and hopefully over the next few years a breakthrough in treatment."

 

Pass is continuing his work, which is funded by a grant from the National Cancer Institute (NCI). In fact, his NYU facility has been designated a "biomarker laboratory" by the NCI, he said.

 

Pass and his colleagues will soon start screening banked blood samples from mesothelioma patients. That and future studies will aim at determining the exact levels of osteopontin that could be used in a screening test.

 

"If we find the same relationship with banked serum [blood] -- something that should take two years -- and if the marker holds up, then we can proceed to a prospective trial to see if it finds mesothelioma early," he said.

 

About 2,500 cases of mesothelioma are reported in the United States each year, Pass said, although he believes the cancer might be underdiagnosed because there is no official registry for it. Only 5 percent of cases are detected early, Pass said. The life expectancy for those diagnosed late is just nine to 12 months.

 

However, detected early, mesothelioma "does respond to therapy," he said. Treatments include radiation therapy, chemotherapy and surgery.

 

source: Ed Edelson, HealthDay

 

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or defend
your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
__________________________________________________

Smiths Medical Launches GRIPPER PLUS(R) Safety Needles with Enhanced Needlestick Safety

ST. PAUL, Minn.--(BUSINESS WIRE)--March 23, 2006--Smiths Medical MD, Inc. has added a new version of their popular GRIPPER PLUS(R) Safety Huber Needles to the existing product line. The new GRIPPER PLUS(R) Safety Huber Needles with a luer-activated needleless access connector will allow direct connection of a syringe or tubing with standard luer accommodating additional patient therapies. With this addition to the GRIPPER PLUS(R) needle product line, Smiths Medical now offers three configurations of the extension set that connect to the needle, including a non-auxiliary site, a split septum needleless access auxiliary site, and the new luer-activated needleless access auxiliary site.

GRIPPER PLUS(R) Safety Huber Needles are used to deliver medications intravenously through a patient's implanted port. Their unique feature is a safety arm that is lifted to lock the needle into a protected position when de-accessing it from an implanted port. An audible click provides clinicians with confirmation that the de-accessed needle is in its locked safety position. With the addition of a needleless access site, GRIPPER PLUS(R) Safety Huber Needles continue to be an important part of an organization's needlestick safety program.

Smiths Medical has sold millions of GRIPPER PLUS(R) Safety Huber Needles since their launch in 2002.

Smiths Medical is a world leader in the design, manufacture, and distribution of medical devices used in infusion therapy, including CADD(R) ambulatory infusion pumps, PORT-A-CATH(R) implantable access systems, GRIPPER PLUS(R) safety huber needles, CliniCath(R) PICC infusion catheters, and the CozMore(R) insulin technology system. Headquartered in St. Paul, MN, Smiths Medical MD (Medication Delivery) is part of Smiths Group, London, and is committed to developing the highest quality, most reliable products to provide innovative, convenient and cost-effective drug delivery worldwide. For more information, visit www.smiths-medical.com or call 1-800-426-2448.

Contacts

Smiths Medical MD, Inc., St. Paul
Marketing Communications:
Terri Servais, 651-628-7248
E-mail: terri.servais@smiths-medical.com

Caring Today Magazine: Worthwhile, But Somewhat Superficial

Caring Today

 

by Phyllis Fine, Wednesday, March 22, 2006
WHEN DANA REEVE, ARGUABLY America's most famous caregiver, died recently, the obits mentioned she'd given up an acting and singing career to devote herself to her husband, paralyzed movie star Christopher Reeve (now deceased too, of course).

 

Dana, described as a model of graceful serenity in her caregiving role, often noted that she had no bitterness about her sacrifice.

 

As profiled in the magazine Caring Today, then-19-year-old Bridget Bennett also gave up her acting dreams to become a caregiver for her mother, Helene, a breast cancer victim. And as far as I'm concerned, Bridget made an even bigger sacrifice. Helene told Bridget it was time for her to quit college, where she was a theater and journalism major, and go into the family business--home and car insurance. "It's not something I had dreamed of doing," Bridget is quoted as saying, "but I enjoy working with the people." As with all accounts of Dana Reeve, Bridget's story focuses on the positive: "My mother's illness has made me more spiritual" and inspired her to lose 80 pounds, Bridget says.

 

I'm sure if I were a caregiver, I'd be heartened by this story, but also a little pissed off at getting only the superficial side. Where is the anger and ambivalence that Bridget must have felt, having to stop the fun of acting classes to attend "the Professional Insurance Agent school"?

 

While Caring Today does a competent job of fulfilling the mission in its tagline--providing "practical advice for the family caregiver"--digging a little deeper would serve its readers well and spice up a sometimes-bland mix of articles, like a boring food column and the front-of-the-book medical items, which are way too long and read like press releases.

 

The longer medical features are better. A three-part diabetes section targets readers smartly, focusing on the subtle surface symptoms of the disease in teeth, skin and feet that caregivers need to watch for. "Understanding Arthritis" puts the condition in context as the nation's leading cause of disability, discussing its various permutations and treatments simply enough so that even a medical idiot (me, for instance) could understand.

 

"Gentle Travel Adventures" helpfully discusses the accessibility of three U.S. cities, but is marred by its generic travel brochure style, complete with the worst fault of the genre, the baffling mention of a supposedly world-famous sight: Chattanooga's Ross's Landing, "where the infamous Trail of Tears began"--what trail? What tears? The blurb with the story asks a good question that never gets answered: "If your traveling companion has a physical disability, you face a unique challenge. So, how do you get the real break you need?" A first-person approach here, maybe describing how a caregiver went on a trip and balanced her needs with those of her charge, would have livened things up considerably.

 

A story about a New Hampshire-based breast cancer support group--"Oh, Those Breast Friends!"--thankfully livens its inspirational tone with humor, like the mention of The Young and The Breastless, a rock band one of the support group's members wanted to form.

 

Though I'm not usually big on reader-written stories, the best piece in this issue is one penned by a reader, Ami S., about the dog that takes care of Ami's Alzheimer's-stricken mother. Any tendency toward the maudlin is counterbalanced by Ami's clear-eyed voice and detailed focus on a dog who does everything short of putting on a nurse's uniform and asking, "How are we feeling today?" Madison, the dog, "wears a backpack containing a change of clothes, medicine, money, ID and other things my mother needs but no longer can keep track of, recognize or carry." Ami even claims that Madison "can hand a clerk a credit card (but won't sign for the purchase)."

 

Since it's the real-life stories that shine, it's particularly disturbing that Caring Today's cover photos are actually posed model shots. In place of the March/April phony cover, I wish the mag's editors had chosen a great inside photo of Bridget, the young caregiver, with her mother, Helene: Helen is wearing that chemo-bald look, which makes the photo more genuine still.

 

If Caring Today's editors want to be heartwarming, they should focus more on the real heart of the mag's topic, and forget the generic photos and text.

 

Phyllis Fine is columns editor for MediaPost.

 

Magazine Rack for Wednesday, March 22, 2006:
http://publications.mediapost.com/

 

--------------------------------------------------------------------------------
If this issue was forwarded to you and you would like to begin receiving a copy of your own, please visit our site - www.mediapost.com - and become a complimentary member.
--------------------------------------------------------------------------------
We welcome and appreciate forwarding of our newsletters in their entirety or in part with proper attribution.
(c) 2006 MediaPost Communications, 1140 Broadway, 4th Floor, New York, NY 10001

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
http://www.drug-store-directory.com
__________________________________________________

Quest for Cure of Asbestos Joinded By Asbestos Workers Union

Asbestos Workers Union Joins New Medical Foundation's Quest for Cure of Asbestos and Benzene-Related Cancers
               
LOS ANGELES, March 20 /PRNewswire/ -- The Pacific Heart, Lung and Blood Institute ("PACHLAB") is pleased to announce the addition of Terry Lynch as a member of its Board of Directors.  PACHLAB is a 501(c)(3) non-profit medical research foundation devoted to the prevention, diagnosis, and treatment of occupational diseases through independent research, collaboration, and education.

 

Terry Lynch is Vice President at Large of the International Association Heat & Frost Insulators & Asbestos Workers and also serves as the Health and Safety Director for the Union.  He comes from a proud family of asbestos insulators, which include his grandfather, father, uncle, brother, and many cousins.  Mr. Lynch's son, Jason, now completes the family's fourth generation of insulators.  Over the years, Mr. Lynch has witnessed first hand the ravages of asbestos on the lives of countless Union brothers.

 

"The suffering must stop," Mr. Lynch said.  "Too many insulators and other working people have died.  We have known about asbestos cancer for decades, yet not enough has been done to lift the curse of mesothelioma.  We must work with industry, government, doctors, and drug companies to establish research programs that will end the apathy and build hope."

 

"I am proud to join PACHLAB," Mr. Lynch continued.  "We will be conducting research in the Punch Worthington lab at the David Geffen School of Medicine at UCLA.  We have high expectations that our research will lead to novel treatments."  Mr. Lynch will act as a liaison between PACHLAB and construction and shipyard labor unions whose members are at risk for asbestos and benzene-related cancers.

 

Dr. Cameron, one of PACHLAB's scientific advisors, stated, "I have agreed to work closely with PACHLAB because it offers a unique approach to collaborative research.  Not only will we work with patients, doctors and donors to raise funds for promising new research, we will actually do the bench work studies in-house, either alone or in conjunction with other investigators."

 

"'Punch' Worthington is a patient of mine who suffers from an asbestos-related cancer," Dr. Cameron explained.  "As a painter-taper, Punch is also at risk for another occupational cancer, acute myelogenous leukemia.  We came up with the idea for a research environment that fosters basic research that is often pegged as too preliminary to receive funding from standard sources. This type of research, although highly speculative, also holds the most promise for true innovation."

 

PACHLAB's first project will study immunologic and anti-angiogenic (anti-blood vessel) therapies, both of which have been praised as potential "cures" for mesothelioma.  PACHLAB aims to conduct research in its own laboratory and in coordination with other institutions, such as the David Geffen School of Medicine at UCLA.

 

"This is a true 21st Century approach to medical research," Cameron continued, "And is the brainchild of Punch Worthington who is a true scientist and scholar.  Punch believes, for instance, that bringing all the parties involved in asbestos litigation together to support and fund this type of research by donating a portion of legal settlements, will accelerate the long overdue discovery of truly effective therapies for this awful disease.  With heroes like Punch, scientists like myself cannot help but take up the challenge."

 

Also joining PACHLAB's Board of Directors is Terry McCann of Dana Point, California.  Mr. McCann, who was diagnosed with malignant mesothelioma in 2005, has led an exemplary life.  He won the Olympic Gold Medal in wrestling in 1960.  He helped manage the Surfriders Foundation, served on several Olympic Games committees, and was the CEO of Toastmasters International for 25 years.

 

Contact:  Robert Cameron, MD
Pacific Heart, Lung & Blood Institute
11818 Wilshire Boulevard, Suite 200
Los Angeles, CA  90025
Tel:  (310) 622-4960
Fax:  (310) 231-2131
E-Mail: info@phlbi.org
http://www.phlbi.org

 

SOURCE Pacific Heart, Lung and Blood Institute
Web Site: http://www.phlbi.org

Mesothelioma Associated With Exposure to Volcanic Mineral

Exposure to volcanic mineral associated with increased mesothelioma incidence in Turkey

High exposure to a fibrous volcanic mineral called erionite was associated with a high incidence of a type of cancer called mesothelioma, according to a study in the March 15 issue of the Journal of the National Cancer Institute.

Public release date: 14-Mar-2006 - Many cases of environment-related mesothelioma have been reported in the Cappadocia region or Anatolian plateau of Turkey. Blocks of erionite from volcanic tuff have been used in construction, and storage rooms for produce have been cut in the tuff. Past reports have suggested that erionite exposure may increase the risk of mesothelioma, and studies have shown that erionite is associated with a higher risk of cancer development in animals than any other fiber previously tested.

Y. Izzettin Baris, M.D., of Hacettepe University in Ankara, Turkey, and colleagues followed 891 men and women age 20 years and older in three villages in Turkey – two exposed to erionite, one control – for 23 years. During this period, 372 deaths occurred, and 119 of these deaths occurred from mesothelioma. This form of cancer mainly affects the lining of the lung and was the cause of 44.5% of all deaths in the two villages with erionite exposure. Only two cases of mesothelioma occurred in the control village, both in people born outside of the control village.

The mortality data were analyzed jointly with Philippe Grandjean, M.D., Ph.D., of the Harvard School of Public Health. When standardized to the world population, the annual incidence of pleural mesothelioma in the two exposed villages was 200 and 700 cases per 100,000 people annually, compared to a rate of 10 cases per 100,000 people each year in the control village. The authors conclude that the long-term exposure to erionite is the cause of the exceedingly high risk of developing mesothelioma.

"Our results emphasize the severity of the mesothelioma endemic in erionite-exposed areas of Turkey," the authors write. They add, "In the rural part of central Anatolia, Turkey, millions of inhibitants are likely exposed to hazardous amounts of mineral fibers from the environment. Resources should therefore be directed to preventing these environmental exposures and additional study of the association between environmental exposure to nonasbestos fibers and the risk of cancer."

###

Contact: Christina Roache, Office of Communications, Harvard School of Public Health, 617-432-6052, croache@hsph.harvard.edu

Citation: Baris YI and Grandjean P. Prospective Study of Mesothelioma Mortality in Turkish Villages With Exposure to Fibrous Zeolite. J Natl Cancer Inst 2006; 98: 414-417.

Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oxfordjournals.org/.

Contact: Ariel Whitworth
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or
defend your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
__________________________________________________

Healthcare Statistics, Facts, And Figures From 2005 Research Studies Offered

 

Healthcare Research Tool Consolidates 12 Months of Industry Data on Searchable CD-ROM

A new searchable electronic resource compiled by the Healthcare Intelligence Network (HIN) places the latest healthcare statistics, facts and figures from 2005 research studies at the fingertips of industry professionals. The Healthcare Daily Data Bytes 2006, a keyword-searchable database on CD-ROM, is aimed at healthcare professionals researching new projects, writing reports and compiling presentations. This resource allows users to get the healthcare statistics and figures they need from the leading healthcare consulting firms, think tanks and research and government institutions—without having to wade through periodicals, journals and other documents or conduct Internet searches for that one piece of necessary data.

Manasquan, NJ (PRWEB) March 14, 2006 -- A new searchable electronic resource compiled by the Healthcare Intelligence Network (HIN) places the latest healthcare statistics, facts and figures from 2005 research studies at the fingertips of industry professionals. The Healthcare Daily Data Bytes 2006, a keyword-searchable database on CD-ROM, is aimed at healthcare professionals researching new projects, writing reports and compiling presentations.

This resource allows users to get the healthcare statistics and figures they need from the leading healthcare consulting firms, think tanks and research and government institutions—without having to wade through periodicals, journals and other documents or conduct Internet searches for that one piece of necessary data. For more information, please visit http://www.hin.com/cgi-local/link/news/pl.cgi?databytepr.

Compiled each business day in 2005 from the most current research available, each of the more than 250 Data Bytes on the CD-ROM contains an abstract of a newly announced healthcare research study, a link to the original study source and a related resource. Users can conduct instant keyword searches on the latest findings in consumer-driven healthcare, disease management, e-health, wellness, Medicare, Medicaid, pay-for-performance, and many other areas. Search results are returned by relevancy and can be printed for easy reference.

According to Melanie Matthews, HIN executive vice president and chief operating officer, the Healthcare Daily Data Bytes 2006, Keyword Searchable CD-ROM is drawn from the Data Bytes that HIN publishes each business day for its clients in the healthcare industry. “So often industry professionals are seeking that one statistic to back up a proposal or budget request or complete a research effort,” Matthews states. The Healthcare Daily Data Bytes 2006 facilitates these tasks by putting a year’s worth of current studies in one electronic tool. “In the time that it takes to hit the “Enter" key, the information appears on the user’s computer screen. With one more keystroke, it can be saved to a file or sent to a computer printer.”

The 2006 edition of Healthcare Daily Data Bytes contains statistics on hundreds of topics, including the following:
* Cost of Chronic Health Conditions;
* Employers Adopting Health Management, Consumer-Directed Programs to Control Costs;
* Growth of Consumer-Driven Healthcare Plans;
* Impact of Medicare Payment Cuts;
* Most Popular Form of Health Insurance;
* Pay-for-Performance Results Show Improvements in Healthcare;
* Performance Gap Narrows Between Successful Medical Groups and Others;
* Quality Report Cards: Improves Ability to Identify Best Providers by Racial Minorities;
* Survey Sheds Light on Key Regional Health Information Organizations Benefits and Issues; and
* Women's Health in the United States Shows Patterns by State for Key Indicators.
In addition to these studies, the CD-ROM contains more than 200 other relevant findings. For more information, please visit http://www.hin.com/cgi-local/link/news/pl.cgi?databytepr.

About the Healthcare Intelligence Network—HIN is the premier advisory service for executives seeking high-quality strategic information on the business of healthcare. For more information, contact the Healthcare Intelligence Network, PO Box 1442, Wall Township, NJ 07719-1442, (888) 446-3530, fax (732) 292-3073 or visit http://www.hin.com.

Contact:
Patricia Donovan
Phone: (732) 528-4468
Fax: (732) 292-3073

# # #

Press Contact: Patricia Donovan
Company Name: HIN
Email: email protected from spam bots
Phone: 732-528-4468
Website: http://www.hin.com/cgi-local/link/news/pl.cgi?databytepr.

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or defend
your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
http://www.drug-store-directory.com
__________________________________________________

Chemotherapy Pump May Provide Options

 

Kinder, Gentler Chemotherapy

With the advent of technology brought to the U.S. from France, having to postpone, even stop, regular life activities to go to a chemo ward to receive chemotherapy treatments, may be a thing of the past. Utilizing a portable, computerized pump that can fit in a fanny pack, patients receive their chemotherapy at a time when it will be most effective and least toxic.

Evanston, IL (PRWEB) March 13, 2006 -- With the advent of technology brought to the U.S. from France, having to postpone, even stop, regular life activities to go to a chemo ward to receive chemotherapy treatments, may be a thing of the past. Utilizing a portable, computerized pump that can fit in a fanny pack, patients receive their chemotherapy at a time when it will be most effective and least toxic.

"Using a portable, computerized pump to deliver chemotherapy allows patients to participate in normal daily activities such as walking, jogging, yoga, and even sleeping while they are receiving their treatments," states cancer specialist Keith Block, MD, who brought this technology to the U.S, and is a member of the National Cancer Institute’s PDQ Cancer CAM Editorial Board. “This unique pump allows for a more specialized method of chemotherapy administration than just modifying the timing of the drug alone. This revolutionary delivery system has demonstrated in large randomized trials its potential to improve survival."

One patient, LisaAnn McConnell, used to go in-line skating along Lake Michigan wearing that special fanny pack. Little did anyone know that the fanny pack she wore was administering chemotherapy for her colon cancer.

"It allows for larger doses to be delivered more frequently, with higher efficacy and lower toxicity," said pioneering chronobiologist Dr. William Hrushesky, a senior clinical investigator at the Dorn VA Medical Center in South Carolina, one of just a handful of U.S. locations that offers chronotherapy. "It's kinder, gentler and at the same time, more aggressive and effective."

"Every drug has an optimal time when it is least toxic and most effective," says Dr. Block. "For cancer treatment, this is determined by several factors, including the biological uniqueness of the particular drug being given, the time when the specific type of cancer cells divide the most, when the normal healthy cells of the patient generally divide the least, the patient’s circadian clock and individual rest-activity cycles, and even the time zone the person resides in."

"We have found that often patients receiving their chemotherapy this way reduce what would have been recurring side effects of nausea, vomiting, diarrhea, and fatigue," explained Dr. Block cofounder and Medical/Scientific Director of the Block Center for Integrative Cancer Care, and Director of Integrative Medicine Program at the University of Illinois College of Medicine at Chicago. This is important because the debilitation caused by chemo can cause patients to reduce or even stop treatments that could otherwise help them win their battle with cancer." In fact, current research shows that up to 1/3 of chemotherapy patients abandon treatments prematurely due to the side effects.

According to Dr. Block, "Even after prior treatments have failed patients, using our specialized pumps to administer chronomodulated chemotherapy, we have been able to re-challenge these same patients with the identical drug regimen and this time around gotten successful results."

McConnell, who was diagnosed with colon cancer at age 46, is the third generation in her family to have been diagnosed with this form of cancer, and until now there have been no survivors. “I’m happy to say that my doctors now think that my cancer is 100% gone,” says McConnell, now 47.

The Block Center for Integrative Cancer Care located in Evanston, Illinois, was founded in 1980 by Penny and Keith Block, M.D., committed to the unrelenting belief that no cancer patient should ever be given up on, and with a focus on treating the patient as a whole person, not simply treating the diagnosis. The Center's research-based treatment integrates an innovative approach to the best of conventional medicine with scientifically sound complementary therapies -- therapeutic nutrition, botanical and phytonutrient supplementation, prescriptive exercise, and systematic mind-body strategies, to enhance the recovery process. Block has pioneered this "middle ground" approach to cancer care and optimal health -- designing a total treatment plan that is tailored to the precise needs of each patient, using a unique set of clinical and laboratory assessments. The Block Center is breaking new ground with the creation and development of Cancer Rehab as an innovative treatment modality, and is currently the only private North American medical center using chronomodulated chemotherapy. Dr .Block is a member of the National Cancer Institute’s PDQ Cancer Complementary and Alternative Medicine (CAM) Editorial Board in Washington, D.C. While the Block Center is a full treatment clinic, it is also officially a CCOP site through the National Cancer Institute, and is engaged in clinical cancer research with the University of Illinois and other university facilities in the United States and Israel (www.blockmd.com)

# # #

Press Contact: Betty Hoeffner
Company Name: HOEFFNER PR GROUP, LTD.
Email: email protected from spam bots
Phone: 773 348 8681
Website: http://www.blockmd.com

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or defend
your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/expert.html
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
http://www.drug-store-directory.com
__________________________________________________

Asbestos Mining Victims Gain Another Victory

Another Victory For Asbestos Mining Victims
---------------------------------------------------------------

By Sizwe samaYende

07 Mar 2006 - Nelspruit - There is hope of compensation in sight for more asbestos miners who contracted diseases and other life-threatening ailments because of their jobs. Nelspruit-based lawyer Richard Spoor has brokered a deal with Swiss Eternit Group, a multinational company, to establish a trust that will pay the workers for the next 20 years.

The Kgalagadi Relief Trust will pay individuals who used to work at the group's asbestos mines at Kuruman and Danielskuil in the Northern Cape between 1952 and 1981. Spoor said the structure and organisation of the trust would be modeled on the existing Asbestos Relief Trust.

The Asbestos Relief Trust, which Spoor was instrumental in creating, was established in 2003 following an out-of-court settlement between asbestos sufferers and their former bosses, Msauli, Gencor and Gefco. The three companies agreed to set aside R460 million to compensate ex-workers from mines in Mpumalanga, Limpopo and the Northern Cape.

This trust's formation followed a victory by about 7 000 asbestos victims who used to work for British multinational company, Cape Plc.

 

Cape Plc's employees set a precedent by forcing the company to pay about R97 million in 2001 to compensate sickly workers and relatives of workers who had died from asbestos-related diseases. "To avoid unnecessary duplication, the Asbestos Relief Trust will be entrusted with the management and administration of the new trust," Spoor said.

He declined to reveal how much Swiss Eternit Group set aside for the compensation of its ex-worker s but said that both parties were satisfied that "the grants payable to qualifying applicants are fair and equitable."

 

"The contributions are confidential but [we] are confident that they will be sufficient to enable the trust to fulfill its obligations to beneficiaries," said Spoor. Spoor added that the Kgalagadi Relief Trust would become active from the beginning of next month.

Meanwhile, the Asbestos Relief Trust was planning to set up claim offices in the neighbouring countries of Mozambique, Swaziland and Lesotho this year to facilitate the compensation of ex-workers from these countries. This trust has approved about R100.9 million to date, to be paid to qualifying ex-mineworkers. - BuaNews

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or defend
your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/expert.html
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
http://www.drug-store-directory.com
__________________________________________________

New Asbestos Challenge Faced By Mesothelioma Widows

Widows face new asbestos challenge

Lawyers representing mesothelioma sufferers and their families are facing a challenge to victims’ continued right to compensation for the deadly asbestos cancer, mesothelioma, in a hearing in the House of Lords due to start on Monday, March 13.

Sylvia Barker and Mary Murray will face arguments that the law should be changed to stop them being compensated in full for losing their husbands to the fatal disease, because some of the companies responsible have vanished or were not insured.

If successful, the appeal, by successors of employers in the shipbuilding and steelmaking industries, could deprive thousands of claimants of their full entitlement to compensation for mesothelioma. The hearing in London between 13 – 15 March follows the defeat of insurers’ attempt to end compensation for mesothelioma in the Fairchild test cases in the House of Lords in 2002. The insurance industry is watching developments in the appeal which, if successful, could save insurers millions of pounds.

The legal team representing the families includes the specialist law firms Thompsons Solicitors and John Pickering & Partners.

Ian McFall, Head of Asbestos Litigation for Thompsons Solicitors, who act for Mrs. Murray, explains: "What we will be asking the Law Lords to do is simple - uphold the law which requires negligent employers and their insurers to pay full compensation to mesothelioma sufferers and their families. Anything less will be an injustice."

Mary Murray, 84, from Sunderland, Tyne & Wear comments: “I have had 7 years of misery since John died from this terrible disease. I would rather have him back any day and they could keep the money. But it was the employers’ fault he was taken away from me. I just think employers and insurance companies care more about the money than they do about being fair to people like me and my husband who suffered so much.”

Representing Mrs Barker, James Thompson from Pickering & Partners comments: “If these appeals succeed, mesothelioma sufferers and their families could be deprived of 50% or more of their compensation. Severe financial hardship would result from awards being slashed in many cases by tens of thousands of pounds, so that guilty employers and their insurers can save money.”

Sylvia Barker, 58, of Hollywell, Flintshire said: “I’m angry that after these people took away Vernon’s life, they are adding insult to injury. They admitted that they should have protected him from asbestos. Why should they get the law changed to save them paying for what they have done?”

The House of Lords will be asked to decide on a second, important issue in Mrs Barker’s case: whether compensation should be denied altogether when a mesothelioma sufferer was in contact with asbestos during a period of self-employment, even if, like Mrs Barker’s late husband, they were also exposed to asbestos in a different period as an employee.

The important issues of law and policy in these cases will have far reaching implications for mesothelioma cases throughout the UK: 1,800 people die each year of mesothelioma and the numbers are rising. Many had contact with asbestos in more than one job. It is common for employers to have ceased trading, with no trace of their insurers.

The majority of people diagnosed with mesothelioma were innocent employees who were exposed to asbestos at work without being warned of the dangers.

Ends

For further information please contact:
Thompsons Solicitors:
Ian McFall,
Head of Asbestos Litigation
Thompsons Solicitors
0191 2690 488 / 0797 0728 184

Katie King, Thompsons Press Office
Mobile: 07974 161 179
Email: thompsons@2thefore.biz

John Pickering and Partners:
James Thompson, partner:
0161 633 6667 / 07976 896224
jt@johnpickering.co.uk

Paul Glanville or Ruth Davies 01422 345535
Carol Ann Hepworth 0161 834 1251
Kevin Johnson 0151 227 1214

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or defend
your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/expert.html
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
http://www.drug-store-directory.com
__________________________________________________

Hypnosis Download Now Available To Help Stop Smoking

 

Stop Smoking Hypnosis Download Now Available

A downloadable version of a successful hypnosis CD to stop smoking is now available at www.EasilyStopSmoking.com at a discounted price for a limited time.

London, UK (PRWEB) March 8, 2006 -- EasilyStopSmoking.com, the most successful stop smoking hypnosis system, announces the availability of a downloadable version of its hypnosis CD to quit smoking at less-than-half of the normal CD price. The price discount is available only for a limited time and can be ordered at http://easilystopsmoking.com/downloadCD.php.

The CD was created by a hypnotherapist named Randy Charach who has been helping people change their lives and quit smoking for over 20 years. He has worked with celebrities like John Travolta, Madonna and Sean Penn. EasilyStopSmoking.com founder and director Martin Popham arranged for the rights to sell the product after he and his wife had both used the product and succeeded with it. It took him less than a week to quit smoking using the hypnosis, when he once smoked 40 cigarettes a day for 18 years.

The stop smoking hypnosis program is just like a session in the office of a hypnotherapist. The site now offers a free audio sample, so potential users can listen and know exactly what to expect from the treatment before purchasing.

The success rate of the program is around 93.2%, which is one of the highest rates of any hypnosis product on the market. There is a money-back guarantee within 60 days for customers who are not completely satisfied.

Many people have tried hypnosis without success, but Martin says that those people should not give up. “People are too incredibly busy and stressed these days. It’s hard to rush off down to the doctor’s office and be able to sit and relax enough to go under the spell and achieve success. Our program is one which is designed to be listened to in the evening while in bed or while relaxing in a quiet room, and due to the convenience factor, the success rate is much higher.”

The downloadable file is available in MP3 and WMA formats and is available for $37 (approximately £20). Users have access to the download page for 30 days so they may access the file as much as they wish in that time. It will work with Windows Media Player or any other audio or media player and can be burned onto a CD or uploaded in an MP3 player to be used anywhere. The file is just over 30 megabytes in size, so users with a slow internet connection should consider ordering the CD instead (which sells for $77, or approximately £43) and this option now comes with free shipping worldwide.

“The low price and quick access to the product through the download will make it more accessible to everyone,” Martin said. “When you are a smoker, and you really and truly find a way to quit, you want to share it with as many people as possible.”

About EasilyStopSmoking.com (www.easilystopsmoking.com) –
EasilyStopSmoking.com, based out of London, UK, has used its stop smoking hypnosis program to help nearly 1000 people from all over the world stop smoking in only six months of operation. Company founder and director Martin Popham began sharing the program with others after his personal battle with smoking was successful after using the treatment. New features on the site include an audio sample and the availability of both MP3 and WMA files.

Contact:
Martin Popham
Founder and director
07890 803858
http://www.easilystopsmoking.com

# # #

Press Contact: Martin Popham
Company Name:
Email: email protected from spam bots
Phone: 00353 86053 1144
Website: http://www.EasilyStopSmoking.com

Your submission to Mesothelioma-Search-Engine.com has  been accepted.

The site is scheduled to be spidered and indexed soon.

______________________________________________
FREE 1 Year Technology and Business Magazine Subscriptions!

Subscribe to many leading magazines absolutely
FREE. There are absolutely no hidden or trial offers,
and no purchase necessary. Publications are
absolutely free to those who qualify.

Click here to subscribe!
http://consultant-directory.tradepub.com/
_______________________________________________

Free Home Medical Equipment Photo Ads at
http://www.Home-Medical-Equipment-Classifieds.com
____________________________________________
Free Medical and Lab Equipment Classified Ads at
http://www.Medical-Equipment-Classifieds.com
____________________________________________
Find drug and pharmacy information at
http://www.drug-store-directory.com
____________________________________________
Find Legal Information at
http://www.Legal-Search-Engine.com
____________________________________________

New Guide to Inform Consumers About Patient Safety

 

New Guide Facilitates Partnerships between Hospitals, Public Libraries to Inform Consumers About Patient Safety

A new tool is now available to help organizations develop and provide consumer awareness programming for patient safety. Partnering for Patient Empowerment Through Community Awareness (PPECA), a hospital-library collaborative program, is releasing new content this week. The PPECA Facilitator’s Guide and module presentations are now freely available for organizations to use in their own patient safety educational efforts.

CHICAGO (PRWEB) March 8, 2006 -- National Patient Safety Awareness Week is about promoting the importance of partnership with patients to reduce medical error.

To support other national efforts, Partnering for Patient Empowerment Through Community Awareness (PPECA), a hospital-library collaborative program, is releasing new content this week. The PPECA Facilitator’s Guide and module presentations are now freely available. The modules and guide will provide direction on presenting a patient safety program that hospitals and libraries can host together to increase awareness among consumers about patient safety.

"We felt it was important to participate in a program that shared information on how patients could become proactive partners in their own safe care," stated Carolyn Anthony, Director of Skokie Public Library, one of the PPECA library participants. Roxanne Goeltz, co-founder of Consumers Advancing Patient Safety (CAPS) and consumer speaker on patient safety agreed: “Patients must prepare themselves to be more involved in their healthcare. The atmosphere and resources available at the public libraries partnered with the knowledge and dedication of the hospitals will strengthen the safety net for all patients.”

To develop the PPECA model, five northern Illinois hospitals and public libraries worked together to refine content and the program development process. The free Facilitator’s Guide shares that expertise so others can initiate similar adult education sessions that feature health care practitioners, librarians and consumers as speakers. Program planners who need additional content for their sessions can access streaming video of the presentations from the project Web site at http://www.galter.northwestern.edu/PPECA/index.htm.

PPECA is the first model for building patient safety awareness through participatory community partnerships involving a public library and a healthcare institution. “Public libraries have a history of providing educational programs on topics of interest to their communities,” says Linda Walton, associate director, Galter Health Sciences Library and PPECA principal investigator. “Many people feel more comfortable in a public library environment than in a hospital setting for learning.”

The educational sessions include three short presentations designed to raise consumer awareness of:
•    The consumer’s role in working with healthcare providers to manage risk of avoidable patient injury;
•    Patient-centered clinical and systems-based approaches to patient safety; and
•    Effective medical information gathering to support safe care.

PPECA was developed in collaboration with Consumers Advancing Patient Safety, the Health Learning Center of Northwestern Memorial Hospital, Zipperer Project Management and the Metropolitan Library System. The program has been funded in whole or in part with federal funds from the National Library of Medicine, National Institutes of Health, under Contract. No. NO1-LM-1-3513.

###

Press Contact: Lorri Zipperer
Company Name: ZIPPERER PROJECT MANAGEMENT
Email: email protected from spam bots
Phone: 847-328-5075
Website: http://www.galter.northwestern.edu/PPECA/index.htm.

______________________________________________
FREE 1 Year Technology and Business Magazine Subscriptions!

Subscribe to many leading magazines absolutely
FREE. There are absolutely no hidden or trial offers,
and no purchase necessary. Publications are
absolutely free to those who qualify.

Click here to subscribe!
http://consultant-directory.tradepub.com/
_______________________________________________
Free Home Medical Equipment Photo Ads at
http://www.Home-Medical-Equipment-Classifieds.com
____________________________________________
Free Medical and Lab Equipment Classified Ads at
http://www.Medical-Equipment-Classifieds.com
____________________________________________
Find drug and pharmacy information at
http://www.drug-store-directory.com
____________________________________________
Find Legal Information at
http://www.Legal-Search-Engine.com
____________________________________________

HIV and AIDS Children Get Innovative Solution from FLAVORx

 

FLAVORx Develops Innovative Solution for HIV and AIDS Children -- Company Reaches Out to Children in Thailand and the Dominican Republic

FLAVORx Inc has recently wrapped up studies to provide palatable solutions to combat the bitter taste of antiretroviral HIV and AIDS medications. Because taste plays a crucial role in medicinal compliance, the design of a liquid medication that children can actually swallow allows these young patients to receive the live-saving treatment they need. Due to its success with patients in Thailand and the Dominican Republic, FLAVORx has submitted the manuscript to the CDC, the Clinton Foundation and the Clinical Infectious Diseases Journal.

Bethesda, MD (PRWEB) March 7, 2006 -- FLAVORx, Inc, the company that sets the gold standard in developing scientifically tested medicinal flavorings has expanded its pharmaceutical repertoire to include antiretroviral medications used to treat patients with HIV and AIDS. The company will use its proprietary taste masking agents to improve the existing taste of these medications to increase adherence to drugs and, as a result of improved treatment, lengthen lives. According to Doctors Without Borders, an international medical humanitarian organization, efforts to treat children with HIV and AIDS are hampered by foul-tasting medications. Regardless of a child’s obedience or willingness, in some cases the intolerable taste of a medication will illicit a biological and uncontrollable response that forces rejection of the medication. Many children that are HIV positive do not understand why they must endure a horrible tasting medication when they don’t feel bad. Alternatively, caretakers realize the importance of a life-saving antiretroviral medication but find it extremely difficult to administer to children. This illustrates the point that taste alone can impede a child from receiving treatment necessary for his/her survival.

The World Health Organization estimated that at the end of 2005, 2.3 million children around the world were living with HIV. Of the 3.1 million people who died of AIDS last year, over half a million were children aged below 15 years. These statistics are a sobering reflection of the impact of HIV and AIDS on young lives. During 2005, it is estimated that 700,000 children globally were newly infected with HIV. More than 80% of infections occurred in Africa, with countries in Asia and the Caribbean also seeing an increase in HIV infection numbers among children. Sadly, global child mortality rates show that 25% of newborns infected with HIV die before the age of one, up to 60% die before reaching their second birthday, and most die before they hit the age of five. However, as reported by the United Nations Program on HIV/AIDS, these numbers are markedly different in higher-income countries, with children having access to a wide range of treatment options and often surviving into adulthood. Accordingly, with the proper treatment and resources available in lower-income countries, the world may be able to avoid high rates of infection and death. Critical medications are essential to health and survival.

Zidovudine (Retrovir), an antiretroviral medication manufactured by both GSK (GlaxoSmithKline) and Cipla Pharmaceuticals, was the first drug approved to treat HIV infection, and is commonly recommended for treatment of symptomatic children. The taste is regarded as bitter and metallic, unbearable to the point that some actually stop taking the medication. The consequences of this non-compliance can be life-threatening.

Children have up to 10 times the amount of taste buds as adults, making them much more sensitive to bitter tastes. As reported by Duke University doctors Susan Schiffman and Jennifer Zervakis, the reason why patients fail to take life saving drugs as prescribed may largely be attributed to taste.

The HIV-Netherlands Amsterdam Thailand Research Collaboration recently completed clinical trials with FLAVORx on major antiretroviral medications used for pediatric treatment in Thailand. With each medication and flavor combination tested for safety and effectiveness, FLAVORx developed successful formulations to mask the taste of antiretroviral medications. “The results were extremely positive,” said Kenny Kramm, CEO of FLAVORx, Inc. “We had 100% compliant and much happier pediatric patients who were able to take the proper dosages and follow drug regimens successfully.” The manuscripts have been submitted to the CDC, the Clinical Infectious Diseases Journal and the Clinton Foundation for publishing as a recommendation that flavoring be used in all parts of the world to help HIV-infected children live happier, less traumatic lives. The report also asks for assistance to support impoverished countries.

Based on the experience and data collection from Thailand, FLAVORx is currently working on expanded clinical trials in the Dominican Republic before offering its solution to HIV and AIDS afflicted children in all areas of the world. Dr. Consuela Beck-Sague of the Centro de Familia AIDS Clinic in La Romana noted, “FLAVORx is used to help alleviate much of the trauma associated with children that are on current HIV-ARV medications. It is a huge help to patients and clinicians.”

The FLAVORx FDA-approved flavors and formulary will soon be offered in cooperation with the Clinton Foundation to help children worldwide. If you have worked with children suffering from HIV/AIDS, see how your experience compares to others by taking this short survey: http://www.surveymonkey.com/s.asp?u=64541861562

For more information, please contact Teresa Chen at 800.884.5771, extension 234.

###

Press Contact: Teresa Chen
Company Name: FLAVORX, INC.
Email: email protected from spam bots
Phone: 240.223.0953
Website: www.flavorx.com

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or defend
your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/expert.html
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
__________________________________________________

Health Search Engine Decides What You Are Looking For

 

Fealth.com Unveils Comprehensive Health Search Engine - Vertical Health Search Engine Fealth.com Launched

Fealth.com today unveiled the internets most comprehensive Health Search Engine at http://www.fealth.com. Fealth.com search results provide highly relevant and reliable health information from the vast amount of information available on the Internet. Using industry accepted trust indicators, such as health certifications, to establish high value rankings, Fealth.com filters out irrelevant search results, such as searching for information on a virus though most search engines providing information on computer viruses.

Westlake Village, CA (PRWEB) March 6, 2006 -- Fealth.com today unveiled the Internet's most comprehensive Health Search Engine at http://www.fealth.com. Fealth.com search results provide highly relevant and reliable health information from the vast amount of information available on the Internet. Using industry accepted trust indicators, such as health certifications, to establish high value rankings, Fealth.com filters out irrelevant search results, such as searching for information on a virus though most search engines providing information on computer viruses.

Fealth, derived from fitness and health is available at http://www.fealth.com and is also available for license to internet portals and publishers for integration within their own websites. An initial portal partner, stayhealthy.com which launched in 1995 as one of the first healthcare websites, is using Fealth’s on-demand and highly customizable search solution to compliment and expand its own health related products.

“Fealth is a perfect choice to more than 110 million Internet users who are looking for health information. Cluttered information on the web and lack of a good health search engines cause a significant amount of lost time and effort for any consumer or health care professional.” Said Ravi Kalidindi, founder and CEO of Findica Inc, “Our search engine provides highly qualified and relevant information without having to page though volumes of irrelevant material.”

“Fealth is providing us excellent on-demand and highly customizable health search and information solutions. These solutions fit very well into our portal, were easily integrated and give our visitors incredibly qualified information which compliments our own products.” said John Collins, CEO of StayHealthy.com “We've already received fantastic feedback from our visitors and customers who are finding highly relevant health information that they otherwise would not have found”.

About Findica Inc and Fealth

Findica was founded in 2004 with a vision to become a leading provider of industry specific information and search solutions for internet and corporate users. Fealth.com is its first product providing the best health search and navigation experience on the web. Findica is based in Westlake Village, CA, and may be contacted with questions and investment queries via email; or visit our Web site at http://www.fealth.com

Media Contact
Fuel Marketing
(512) 832-9995

###

Press Contact: Mike Romanies
Company Name: Findica,
Email: email protected from spam bots
Phone: 512 832 9995
Website: http://www.Fealth.com

---

Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
__________________________________________________
Find medical and legal information on Merck Vioxx: 
Visit http://www.vioxx-search-engine.com
______________________________________________
FREE 1 Year Technology and Business Magazine Subscriptions!

Subscribe to many leading magazines absolutely
FREE. There are absolutely no hidden or trial offers,
and no purchase necessary. Publications are
absolutely free to those who qualify.

Click here to subscribe!
http://consultant-directory.tradepub.com/
_______________________________________________
Promote your consulting business with
http://www.Consultant-Directory.com
_____________________________________________
Professional SEO firm submits to over 180 systems
by hand and shares the list so you can do it yourself!
http://www.Best-Free-Search-Engine-List.com
____________________________________________
Free Home Medical Equipment Photo Ads at
http://www.Home-Medical-Equipment-Classifieds.com
____________________________________________
Free Medical and Lab Equipment Classified Ads at
http://www.Medical-Equipment-Classifieds.com
____________________________________________
Find drug and pharmacy information at
http://www.drug-store-directory.com
____________________________________________
Find Legal Information at
http://www.Legal-Search-Engine.com
____________________________________________

New Mesothelioma Offers News

 Most Recent Information and News About Mesothelioma On New Site

A new site launched by TidbitMedia.com (http://www.tidbitmedia.com) this week gives readers a new resource for an extensive variety of in-depth news and info associated with mesothelioma. The site, called allmesotheliomanews.com, can be found at http://www.allmesotheliomanews.com and will be updated daily with the freshest and most interesting morsels of mesothelioma news and updates. FOR IMMEDIATE RELEASE Most Recent Information and News About Mesothelioma On New Site SANTA CLARA, CA - A new site launched by TidbitMedia.com (http://www.tidbitmedia.com) this week gives readers a new resource for an extensive variety of in-depth news and info associated with mesothelioma. The site, called AllMesotheliomaNews.com, can be viewed by following this link: http://www.allmesotheliomanews.com and will be updated daily with the freshest and most interesting morsels of mesothelioma news and updates. Articles will be put up with headlines and a concise blurb about what the article is associated with. This will be a convenient means for those who want to learn more about what mesothelioma is or those who just want to get further information regarding legal help in an easy-to-read arrangement. The site will be a valuable source for users who want to read the most recent mesothelioma news and updates in an efficient manner. The Web site's convenient layout will save readers valuable time without watering down the informational content. If a reader is only interested in reading articles associated with specific legal issues and advice, or any other related subjects, they can use the helpful search bar to look for those specific articles on the site. The simplicity of the articles and the capability to search the site for specific information will enable readers to save time whenever they want to read the latest information concerning mesothelioma. This enables them to spend more time checking other sites, find legal assistance, or do anything else they want to spend their newfound extra time on. AllMesotheliomaNews.com was created by TidbitMedia.com to conveniently meet readers with mesothelioma news and information presented in a format they want to read it. Articles are up for viewing on the site. For more information please contact pr@tidbitmedia.com

_______________________________________________________
Free trade and professional industry magazines are available at
http://www.consultant-directory.tradepub.com
_______________________________________________________
Lung Cancer caused by asbestos exposure is known as
Mesothelioma. Learn more about this killer cancer.
Visit http://www.Mesothelioma-Search-Engine.com
_______________________________________________________
JR Roberts, a Security Expert Witness can help you prosecute or defend
your criminal or negligent liability case in court.
http://www.jrrobertssecurity.com/expert.html
__________________________________________________
http://www.legal-search-engine.com
http://www.vioxx-search-engine.com
__________________________________________________